Ghent University Academic Bibliography

Advanced

Midterm results of the treatment of cartilage defects in the knee using alginate beads containing human mature allogenic chondrocytes

Aad Dhollander UGent, Peter Verdonk UGent, Stijn Lambrecht UGent, René Verdonk UGent, Dirk Elewaut UGent, August Verbruggen UGent and Karl Almqvist UGent (2012) AMERICAN JOURNAL OF SPORTS MEDICINE. 40(1). p.75-82
abstract
Background: The treatment of chondral lesions is still an important challenge for the orthopaedic surgeon. Attempts have been made to restore cartilage lesions by filling the defects with a temporary biocompatible matrix. Purpose: The authors present their midterm experience with the implantation of alginate beads containing human mature allogenic chondrocytes for the treatment of cartilage lesions in the knee. Study Design: Case series; Level of evidence, 4. Methods: A biodegradable, alginate-based biocompatible scaffold containing human mature allogenic chondrocytes was used for the treatment of cartilage lesions in the knee. Twenty-one patients were clinically prospectively evaluated with use of the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) and a visual analog scale (VAS). The mean follow-up time was 6.3 years (range, 5-8 years). Magnetic resonance imaging (MRI) data were analyzed based on the MOCART (Magnetic Resonance Observation of Cartilage Repair Tissue) system, allowing morphologic assessment of the repair tissue. Magnetic resonance images were taken at 1 year of follow-up and at a mean follow-up of 6.1 years (range, 5-7 years). Results: During the follow-up period, the WOMAC and VAS scores improved significantly. No signs of clinical deterioration or adverse reactions to the alginate beads/allogenic chondrocyte implantation were observed. Four failures occurred during the follow-up period in this study (19.05%). The MOCART scores were moderate and remained stable in time. Conclusion: This investigation provided useful information on the efficacy of the implantation of alginate beads containing human mature allogenic chondrocytes for the treatment of cartilage lesions in the knee. The midterm clinical outcome of the presented technique was satisfactory. However, these results were not confirmed by the MRI findings.
Please use this url to cite or link to this publication:
author
organization
year
type
journalArticle (original)
publication status
published
subject
keyword
REPAIR TISSUE, VISUAL ANALOG SCALE, TRANSPLANTATION, IMPLANTATION, MICROFRACTURE, REGENERATION, RELIABILITY, RABBITS, LESIONS, cartilage, HUMAN ARTICULAR CHONDROCYTES, implant, knee, alginate, chondrocyte, allogenic
journal title
AMERICAN JOURNAL OF SPORTS MEDICINE
Am. J. Sports Med.
volume
40
issue
1
pages
75 - 82
Web of Science type
Article
Web of Science id
000298857200010
JCR category
ORTHOPEDICS
JCR impact factor
4.439 (2012)
JCR rank
1/63 (2012)
JCR quartile
1 (2012)
ISSN
0363-5465
DOI
10.1177/0363546511423013
language
English
UGent publication?
yes
classification
A1
copyright statement
I have transferred the copyright for this publication to the publisher
id
2055939
handle
http://hdl.handle.net/1854/LU-2055939
date created
2012-03-01 16:26:32
date last changed
2012-03-21 13:38:38
@article{2055939,
  abstract     = {Background: The treatment of chondral lesions is still an important challenge for the orthopaedic surgeon. Attempts have been made to restore cartilage lesions by filling the defects with a temporary biocompatible matrix. 
Purpose: The authors present their midterm experience with the implantation of alginate beads containing human mature allogenic chondrocytes for the treatment of cartilage lesions in the knee. 
Study Design: Case series; Level of evidence, 4. 
Methods: A biodegradable, alginate-based biocompatible scaffold containing human mature allogenic chondrocytes was used for the treatment of cartilage lesions in the knee. Twenty-one patients were clinically prospectively evaluated with use of the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) and a visual analog scale (VAS). The mean follow-up time was 6.3 years (range, 5-8 years). Magnetic resonance imaging (MRI) data were analyzed based on the MOCART (Magnetic Resonance Observation of Cartilage Repair Tissue) system, allowing morphologic assessment of the repair tissue. Magnetic resonance images were taken at 1 year of follow-up and at a mean follow-up of 6.1 years (range, 5-7 years). 
Results: During the follow-up period, the WOMAC and VAS scores improved significantly. No signs of clinical deterioration or adverse reactions to the alginate beads/allogenic chondrocyte implantation were observed. Four failures occurred during the follow-up period in this study (19.05\%). The MOCART scores were moderate and remained stable in time. 
Conclusion: This investigation provided useful information on the efficacy of the implantation of alginate beads containing human mature allogenic chondrocytes for the treatment of cartilage lesions in the knee. The midterm clinical outcome of the presented technique was satisfactory. However, these results were not confirmed by the MRI findings.},
  author       = {Dhollander, Aad and Verdonk, Peter and Lambrecht, Stijn and Verdonk, Ren{\'e} and Elewaut, Dirk and Verbruggen, August and Almqvist, Karl},
  issn         = {0363-5465},
  journal      = {AMERICAN JOURNAL OF SPORTS MEDICINE},
  keyword      = {REPAIR TISSUE,VISUAL ANALOG SCALE,TRANSPLANTATION,IMPLANTATION,MICROFRACTURE,REGENERATION,RELIABILITY,RABBITS,LESIONS,cartilage,HUMAN ARTICULAR CHONDROCYTES,implant,knee,alginate,chondrocyte,allogenic},
  language     = {eng},
  number       = {1},
  pages        = {75--82},
  title        = {Midterm results of the treatment of cartilage defects in the knee using alginate beads containing human mature allogenic chondrocytes},
  url          = {http://dx.doi.org/10.1177/0363546511423013},
  volume       = {40},
  year         = {2012},
}

Chicago
DHOLLANDER, AAD, Peter Verdonk, Stijn Lambrecht, René Verdonk, Dirk Elewaut, August Verbruggen, and Karl Almqvist. 2012. “Midterm Results of the Treatment of Cartilage Defects in the Knee Using Alginate Beads Containing Human Mature Allogenic Chondrocytes.” American Journal of Sports Medicine 40 (1): 75–82.
APA
DHOLLANDER, A., Verdonk, P., Lambrecht, S., Verdonk, R., Elewaut, D., Verbruggen, A., & Almqvist, K. (2012). Midterm results of the treatment of cartilage defects in the knee using alginate beads containing human mature allogenic chondrocytes. AMERICAN JOURNAL OF SPORTS MEDICINE, 40(1), 75–82.
Vancouver
1.
DHOLLANDER A, Verdonk P, Lambrecht S, Verdonk R, Elewaut D, Verbruggen A, et al. Midterm results of the treatment of cartilage defects in the knee using alginate beads containing human mature allogenic chondrocytes. AMERICAN JOURNAL OF SPORTS MEDICINE. 2012;40(1):75–82.
MLA
DHOLLANDER, AAD, Peter Verdonk, Stijn Lambrecht, et al. “Midterm Results of the Treatment of Cartilage Defects in the Knee Using Alginate Beads Containing Human Mature Allogenic Chondrocytes.” AMERICAN JOURNAL OF SPORTS MEDICINE 40.1 (2012): 75–82. Print.